Disability prevention and management in leprosy: a field experience

Bombay leprosy project has conducted operational research into cost effective ways of using therapeutic management for prevention of disabilities (POD). The goal of achieving this are broadly divided as 1)prevention of impairments and disabilities(POID) and 2)prevention of worsening of disabilities (POWD). About 33-56% of newly registered leprosy patients already have clinically detectable nerve function impairment (NFI), often no longer amenable to MDT. An analysis of 892 leprosy cases treated with WHO-MD stresses the need to focus attention on leprosy patients...

La chimiotherapie anti-hansenienne face a la nevrite (orieentations nouvelles) / The chimiotherapie anti-hansenienne face has the nevrite (new orieentations).

The mechanisms of activity of chemotherapy, immnunotherapy, antibiotic therapy and surgery in hansenic neuritis are presented. The clinical, bacteriological and pathological pictures of the different types, varieties and stages of neuritis are described and should serve as a guide for the institution of the appropriate therapeutical measures.

Estudo comparativo entre a neuropatia hansenotica e as neuropatias perifericas mais frequentes no nosso meio / Comparative study between the hansenic neuropathie and the more frequent peripheral neuropathies in our way

No diagnóstico diferencial da Neuropatia Hansenótica com as demais Neuropatias Periféricas verificamos que o distúrbio da sensibilidade objetiva e o espessamento do nervo periférico, representam os elementos mais importantes para o diagnóstico.